Key result
Atorvastatin floating microspheres lower rabbit total cholesterol ~74% and improve lipid profiles vs market atorvastatin.
Answers are grounded in this paper and cite their sources.
The purpose of this study was to investigate the influence of hypolipidemic atorvastatin calcium (ATC) floating microspheres on the LDL and HDL level in rabbit blood. Floating microspheres-loaded ATC were prepared via emulsion solvent evaporation method using Eudragit S100 as polymer. The effect of certain variables including drug: polymer ratio, stirring rate, emulsifier concentration and internal: external phase volume ratio on the floating microspheres formulations were performed. Evaluation of floating microspheres was done using particle size analysis, percentage yield, in-vitro buoyancy, entrapment efficiency determination, optical microscopy, in-vitro drug release studies, Thermal analysis (DSC) and Fourier transform infrared spectroscopy (FTIR). The prepared microspheres showed a good floating ability. The Floating microspheres formulation No (F5) revealed the highest %drug released (66%) after 8 h. Furthermore, F5 significantly decreased the blood LDL and increased HDL in comparison with the market drug (ATOR ®) and it succeeded in lowering the rabbit's blood total cholesterol level by 74.42%.
No takes yet. Share an insight, caveat, or question.
Al Zahraa Al Ashmawy (2022) studied Hyperlipidemia (rabbit model). Atorvastatin calcium floating microspheres (formulation F5) vs. Market drug (ATOR) was evaluated on Blood LDL, HDL, and total cholesterol levels in rabbits. Atorvastatin calcium floating microspheres (F5) lowered rabbit blood total cholesterol by 74.42% and significantly improved LDL and HDL compared with market ATOR.
Synapse has enriched 10 related papers. Consider them for comparative context: